Missling has claimed that in some instances trial participant’s brain did not shrink and even improved in volume.
Those claims are so far unsubstantiated and not really worth considering. It just highlights that the analysis must have been done, but only the p-values and some anecdotes are being presented.
Of course the analysts and market in general doesn’t fall for those stunts and like me wants the full context - hopefully 28th July…but so far we have been set up for great expectations only to get disappointed…maybe this time???